4.0
6. Jan. 2009
Mitarbeiter (anonym)
Aktueller Mitarbeiter
East Hanover, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
In a time where the environment for pharma companies is extremely difficult, Novartis has developed a rich pipeline that holds promise for continued growth over the next several years. Novartis has shown a particular commitment to growth, particularly in Oncology.
Kontras
Novartis is not for the faint of heart - many people who work here say they've never been given so much responsibility at other pharma companies. There is a risk of sacrificing depth for breadth. As with any large company, bureaucracy and process can get in the way of driving the business.